Concurrent erythema multiforme and psoriasiform eruption during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.

Di Trolio R, Di Lorenzo G

Open source

DOI
10.22551/2026.53.1304.10352
Published
2026
Container
Archive of clinical cases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.22551/2026.53.1304.10352,
  title = {Concurrent erythema multiforme and psoriasiform eruption during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.},
  author = {Di Trolio R and Di Lorenzo G},
  year = {2026},
  journal = {Archive of clinical cases},
  doi = {10.22551/2026.53.1304.10352},
  url = {https://doi.org/10.22551/2026.53.1304.10352}
}

RIS

TY  - JOUR
TI  - Concurrent erythema multiforme and psoriasiform eruption during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.
AU  - Di Trolio R
AU  - Di Lorenzo G
PY  - 2026
JO  - Archive of clinical cases
DO  - 10.22551/2026.53.1304.10352
UR  - https://doi.org/10.22551/2026.53.1304.10352
ER  - 

APA

R, D. T., & G, D. L. (2026). Concurrent erythema multiforme and psoriasiform eruption during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.. Archive of clinical cases. https://doi.org/10.22551/2026.53.1304.10352

Source records